APOC3 and cardiovascular disorder: Dysregulation of lipid metabolism, which is characterized by elevated levels of triglycerides and APOC3, is associated with metabolic disorders such as obesity, insulin resistance, and cardiovascular disease (Ginsberg et al., 2005).